What is CytomX Therapeutics's net margin?

CytomX Therapeutics (CTMX) reported net margin of -166.4% in Q1 2026.

How has CytomX Therapeutics's net margin changed year-over-year?

CytomX Therapeutics's net margin decreased by 690.2% year-over-year, from 28.2% to -166.4%.

What is the long-term trend for CytomX Therapeutics's net margin?

Over 4 years (2020 to 2025), CytomX Therapeutics's net margin has grown at a -30.0% compound annual growth rate (CAGR), from -94.7% to -22.8%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

CytomX Therapeutics CTMX Net margin

Net margin at other companies

PfizerPFE

15.7%—

AmgenAMGN

21%+3.6pp

Janux TherapeuticsJANX

-833.6%+0.9pp

Allogene TherapeuticsALLO

-1,170,863.6%-2,007,890pp

ImmunomeIMNM

-5,593.8%-11,284pp

Arcus BiosciencesRCUS

-156.4%-47.5pp

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Calculated from CytomX Therapeutics’s reported figures.

net income/total revenue=-166.4%

Based on trailing twelve months.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's net margin?: CytomX Therapeutics (CTMX) reported net margin of -166.4% in Q1 2026.
How has CytomX Therapeutics's net margin changed year-over-year?: CytomX Therapeutics's net margin decreased by 690.2% year-over-year, from 28.2% to -166.4%.
What is the long-term trend for CytomX Therapeutics's net margin?: Over 4 years (2020 to 2025), CytomX Therapeutics's net margin has grown at a -30.0% compound annual growth rate (CAGR), from -94.7% to -22.8%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.